Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Investing

Eli Lilly : LLY

All Eli Lilly Articles

624 Articles

Rich Duprey | Apr 6, 2026 at 10:54 AM EDT

Eli Lilly’s Path to $1 Trillion Runs Directly Through the AI Boom

Eli Lilly (NYSE:LLY | LLY Price Prediction) has built one of the most remarkable growth stories in modern pharmaceutical history…

David Beren | Apr 3, 2026 at 12:10 PM EDT

Novo Nordisk Shares Down 43% in a Year as Generic Rivals Force 48% Price Cuts

One of the world’s leading healthcare names, Novo Nordisk (NYSE:NVO | NVO Price Prediction) cut prices on Wegovy and Ozempic…

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

Michael Williams | Mar 26, 2026 at 2:32 PM EDT

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

Healthcare spending doesn’t stop during recessions. That structural reality is the core argument for owning Vanguard Health Care ETF (NYSEARCA:VHT…

Michael Williams | Mar 25, 2026 at 10:45 AM EDT

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

The S&P 500 you own through a standard index fund is not as diversified as it looks. The cap-weighted version…

John Seetoo | Mar 24, 2026 at 10:07 AM EDT

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

Half of every dollar invested in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) rides on just two companies pulling in opposite directions…

David Moadel | Mar 23, 2026 at 9:34 AM EDT

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) shares are up roughly 2% in Monday morning trading, offering a modest but welcome…

Chris MacDonald | Mar 20, 2026 at 10:02 AM EDT

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

Growth investing has had a choppy start to 2026. The major growth benchmarks are down in the low single digits…

Chris MacDonald | Mar 18, 2026 at 7:00 AM EDT

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Building a seven-figure portfolio from scratch requires one thing above almost everything else: time in the market, compounded through funds…

David Moadel | Mar 17, 2026 at 12:27 PM EDT

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Eli Lilly (NYSE:LLY | LLY Price Prediction) stock is down 5% in Tuesday afternoon trading, with shares falling to $937…

Joel South | Mar 17, 2026 at 12:25 PM EDT

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly (NYSE:LLY | LLY Price Prediction) shares have pulled back sharply, falling 9% over the past month, and 13%…

Rich Duprey | Mar 16, 2026 at 11:19 AM EDT

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Eli Lilly’s (NYSE:LLY | LLY Price Prediction) GLP-1 therapy Zepbound has become the biggest weight loss drug since its introduction,…

Austin Smith | Mar 11, 2026 at 12:37 PM EDT

Josh Brown: Biotech growth stocks immune to disruption risk

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap biotech:…

Joey Frenette | Mar 4, 2026 at 3:30 PM EST

Forget AI. This Biotech Stock’s Taking Off Right Now

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is…

Trey Thoelcke | Mar 2, 2026 at 10:40 AM EST

What Smart Money Loves About Lilly

Eli Lilly (NYSE: LLY | LLY Price Prediction) stock has pulled back 2.9% year-to-date to around $1,044, and institutional investors…

1 2 3 4 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Eli Lilly’s Path to $1 Trillion Runs Directly Through the AI Boom

Novo Nordisk Shares Down 43% in a Year as Generic Rivals Force 48% Price Cuts

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Josh Brown: Biotech growth stocks immune to disruption risk

Forget AI. This Biotech Stock’s Taking Off Right Now

What Smart Money Loves About Lilly

Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Live Nasdaq Composite: Bulls Keep Control on Tech Deals, Chip Profit Growth and Easing Oil

AIRR, PAVE, and XLI: Which Reshoring ETF Wins as Factories Return Home

Shopify Eyes 7% Upside After Brutal 2026 Selloff

Oklo Advances 12% on NRC Aurora Approval: Is This the AI Infrastructure Nuclear Play?

How to Build $2,000 a Month in Dividend Income

Working Past 70 Does Not Grow Your Social Security Check -- Or Does It?

AIRR, PAVE, and XLI: Which Reshoring ETF Wins as Factories Return Home

Shopify Eyes 7% Upside After Brutal 2026 Selloff

Eli Lilly : LLY

All Eli Lilly Articles

Eli Lilly’s Path to $1 Trillion Runs Directly Through the AI Boom

Novo Nordisk Shares Down 43% in a Year as Generic Rivals Force 48% Price Cuts

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VHT Lagged the Market by 57 Points Over 5 Years. Here Is Why Long-Term Investors Still Hold It

3 Equal Weight ETFs Beating the S&P 500 in 2026 as Mega-Cap Dominance Fades

With Two Companies Dictating Everything, IHE Is Riskier Than Most Investors Realize

NVIDIA’s Monday Rebound: What Energy Partnerships and BioNeMo Mean for NVDA Stock

The Only 3 Growth ETFs I Would Buy and Hold Through Any Market

3 Growth ETFs to Buy in 2026 and Hold Until Your Portfolio Hits 7 Figures

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Why One Analyst Thinks LLY Is Worth $850 While the Rest of Wall Street Targets $1,216

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Josh Brown: Biotech growth stocks immune to disruption risk

Forget AI. This Biotech Stock’s Taking Off Right Now

What Smart Money Loves About Lilly

Stock Market Live May 6, 2026: S&P 500 (SPY) Up on End-of-War Hopes Again

Live Nasdaq Composite: Bulls Keep Control on Tech Deals, Chip Profit Growth and Easing Oil

AIRR, PAVE, and XLI: Which Reshoring ETF Wins as Factories Return Home

Shopify Eyes 7% Upside After Brutal 2026 Selloff

Oklo Advances 12% on NRC Aurora Approval: Is This the AI Infrastructure Nuclear Play?

Featured Reads

How to Build $2,000 a Month in Dividend Income

Working Past 70 Does Not Grow Your Social Security Check -- Or Does It?